DekaBank Deutsche Girozentrale’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-26,750
| Closed | -$4.74M | – | 1522 |
|
|
2021
Q3 | $4.74M | Sell |
26,750
-5,000
| -16% | -$654K | 0.01% | 538 |
|
|
2021
Q2 | $3.92M | Buy |
31,750
+8,000
| +34% | +$1.01M | 0.01% | 582 |
|
|
2021
Q1 | $3.15M | Hold |
23,750
| – | – | 0.01% | 595 |
|
|
2020
Q4 | $2.98M | Sell |
23,750
-3,200
| -12% | -$375K | 0.01% | 573 |
|
|
2020
Q3 | $3.02M | Buy |
+26,950
| New | +$2.68M | 0.01% | 507 |
|
|
2019
Q4 | – | Sell |
-249,484
| Closed | -$10.1M | – | 1251 |
|
|
2019
Q3 | $10.1M | Sell |
249,484
-91,400
| -27% | -$3.97M | 0.06% | 265 |
|
|
2019
Q2 | $13.9M | Buy |
340,884
+48,654
| +17% | +$2.01M | 0.07% | 275 |
|
|
2019
Q1 | $15.7M | Buy |
292,230
+76,700
| +36% | +$3.37M | 0.09% | 224 |
|
|
2018
Q4 | $9.19M | Sell |
215,530
-76,700
| -26% | -$3.83M | 0.06% | 277 |
|
|
2018
Q3 | $15.7M | Sell |
292,230
-20,100
| -6% | -$988K | 0.09% | 227 |
|
|
2018
Q2 | $10.6M | Buy |
312,330
+5,000
| +2% | +$182K | 0.07% | 285 |
|
|
2018
Q1 | $12.1M | Buy |
307,330
+288,430
| +1,526% | +$12.3M | 0.08% | 250 |
|
|
2017
Q4 | $658K | Hold |
18,900
| – | – | 0.01% | 772 |
|
|
2017
Q3 | $658K | Hold |
18,900
| – | – | 0.01% | 779 |
|
|
2017
Q2 | $583K | Hold |
18,900
| – | – | ﹤0.01% | 806 |
|
|
2017
Q1 | $505K | Sell |
18,900
-1,500
| -7% | -$39.5K | ﹤0.01% | 738 |
|
|
2016
Q4 | $526K | Buy |
20,400
+1,500
| +8% | +$47.5K | 0.01% | 652 |
|
|
2016
Q3 | $688K | Hold |
18,900
| – | – | 0.01% | 614 |
|
|
2016
Q2 | $661K | Buy |
18,900
+3,000
| +19% | +$97.5K | 0.01% | 625 |
|
|
2016
Q1 | $409K | Sell |
15,900
-900
| -5% | -$26.2K | ﹤0.01% | 692 |
|
|
2015
Q4 | $833K | Buy |
16,800
+300
| +2% | +$10.8K | 0.01% | 589 |
|
|
2015
Q3 | $411K | Buy |
16,500
+800
| +5% | +$24K | 0.01% | 733 |
|
|
2015
Q2 | $497K | Buy |
15,700
+600
| +4% | +$19.4K | 0.01% | 701 |
|
|
2015
Q1 | $575K | Buy |
+15,100
| New | +$600K | 0.01% | 686 |
|
DekaBank Deutsche Girozentrale's XLRN Position: Q4 2021 in Review
DekaBank Deutsche Girozentrale sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 26,750 shares — an estimated $4.74M sold.
DekaBank Deutsche Girozentrale first reported a position in XLRN in Q1 2015 and held it in 24 quarters. The position peaked at $15.7M in Q1 2019. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- DekaBank Deutsche Girozentrale reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 26,750 Acceleron Pharma shares in Q4 2021, an estimated $4.74M.
- DekaBank Deutsche Girozentrale first reported a position in Acceleron Pharma in Q1 2015 and held it in 24 quarters.
- DekaBank Deutsche Girozentrale's Acceleron Pharma position peaked at $15.7M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.